« Return to News | Drug Sponsors

Shire to buy Advanced BioHealing

Wednesday, May 18, 2011 12:10 PM

Ireland-based Shire will acquire the U.S.-based Advanced BioHealing for $750 million in cash, according to Pharma Times.

Shire’s interest is in Advanced BioHealing’s Dermograft, a regenerative bio-engineered skin substitute used for the treatment of diabetic foot ulcers. Shire says Dermagraft has a "favorable reimbursement profile," notably with Medicare (100% coverage), and that generic products "would have to overcome high regulatory, development and manufacturing hurdles" to enter the DFU market.

Advanced BioHealing also has fully enrolled multinational trials to investigate Dermagraft to treat venous leg ulcers.

Mike Cola, president of Shire's specialty pharmaceuticals business, said the acquisition is "a strong and complementary strategic fit." He claimed that "the potential to build on the success of Dermagraft is attractive" as it provides a solution for a common complication suffered by diabetics that, "if not treated effectively, can lead to lower limb amputation and high cost to patients and society."

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.